A Modified Ultrasensitive Assay to Detect Quantified HIV-1 RNA of Fewer Than 50 Copies per Milliliter
- 1 August 2003
- journal article
- research article
- Published by Oxford University Press (OUP) in American Journal of Clinical Pathology
- Vol. 120 (2) , 268-270
- https://doi.org/10.1309/trrq-fwm9-le9h-427m
Abstract
We compared the sensitivity and specificity of versions 1.0 and 1.5 and a modified version 1.5 of the AMPLICOR HIV-1 MONITOR ultrasensitive RNA assay (Roche, Indianapolis, IN) by using a virus stock dilution series and plasma samples from HIV-1-infected and uninfected subjects. The modified assay was linear and consistently positive down to 12 copies per milliliter vs 25 copies per milliliter for the other 2 assays. Versions 1.0, 1.5, and modified 1.5, respectively, detected 9 (23%) of 39, 11 (28%) of 40, and 43 (61%) of 71 replicates of a 4-copy-number and 11 (28%) of 40, 17 (46%) of 37, and 88 (90%) of 98 replicates of a 10-copy-number standard. Of 44 patient samples with undetectable levels using version 1.0, 32 (73%) had detectable levels on the modified assay, and 5 (25%) of 20 had detectable levels on version 1.5. None of the assays detected HIV-1 RNA in HIV-1 antibody-negative samples. The modified version 1.5 of the RNA assay is more sensitive for detecting HIV-1 RNA in significantly more patients than are versions 1.0 and 1.5.Keywords
This publication has 6 references indexed in Scilit:
- Selection of drug-resistant HIV-1 mutants in response to repeated structured treatment interruptionsAIDS, 2002
- Time of initiation of antiretroviral therapy: impact on HIV-1 viraemiaAIDS, 2000
- Predictors of optimal virological response to potent antiretroviral therapyAIDS, 1999
- Cell?Associated HIV?1 RNA in Blood as Indicator of Virus Load in Lymph NodesThe Journal of Infectious Diseases, 1999
- Suppression of plasma viral load below 20 copies/ml is required to achieve a long-term response to therapyAIDS, 1998
- The duration of viral suppression during protease inhibitor therapy for HIV-1 infection is predicted by plasma HIV-1 RNA at the nadirAIDS, 1998